These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Management of the therapy of depression with tricyclic antidepressive agents]. Gram LF; Kragh-Sørensen P; Nagy A; Dencker SJ; Lunde PK Ugeskr Laeger; 1981 Jan; 143(5):252-7. PubMed ID: 7210226 [No Abstract] [Full Text] [Related]
6. [Tricyclic antidepressant plasma levels in depression: a practical guide]. Vis R; Hassink JJ; Vinkers CH Tijdschr Psychiatr; 2013; 55(9):695-705. PubMed ID: 24046248 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic monitoring of plasma concentrations of tricyclic antidepressants. Perspective of the clinical laboratory. Jatlow P Arch Pathol Lab Med; 1980 Jul; 104(7):341-4. PubMed ID: 6893119 [TBL] [Abstract][Full Text] [Related]
8. Should plasma level monitoring of tricyclic antidepressants be introduced in clinical practice? Burrows GD; Davies B; Norman T; Maguire K; Scoggins BA Commun Psychopharmacol; 1978; 2(5):393-408. PubMed ID: 738019 [No Abstract] [Full Text] [Related]
9. Measurement of therapeutic concentrations of tricyclic antidepressants in serum. Gupta R; Molnar G Drug Metab Rev; 1979; 9(1):79-97. PubMed ID: 376258 [No Abstract] [Full Text] [Related]
10. On the role of plasma level monitoring of tricyclic antidepressants in clinical practice. Asberg M; Sjöqvist F Commun Psychopharmacol; 1978; 2(5):381-91. PubMed ID: 738018 [No Abstract] [Full Text] [Related]
12. Mirtazapine--a new antidepressant. Med Lett Drugs Ther; 1996 Dec; 38(990):113-4. PubMed ID: 8988154 [No Abstract] [Full Text] [Related]
13. [The future of antidepressant agents]. Bourin B Encephale; 1996 Dec; 22 Spec No 7():65-8. PubMed ID: 9102335 [No Abstract] [Full Text] [Related]
14. The coming generation of antidepressant therapy. Hooper JF J S C Med Assoc; 1983 Sep; 79(9):471-3. PubMed ID: 6579330 [No Abstract] [Full Text] [Related]
15. Modern tricyclic antidepressant drugs are hardly distinguishable in efficacy or safety for treatment of depressive mood disorders in controlled clinical trials. Glassman AH; Davis JM J Clin Psychopharmacol; 1993 Aug; 13(4):296-9. PubMed ID: 8376622 [No Abstract] [Full Text] [Related]
16. Selecting an appropriate antidepressant. Fish D Practitioner; 1996 May; 240(1562):321-5. PubMed ID: 8917890 [No Abstract] [Full Text] [Related]
17. Therapeutic monitoring of tricyclic antidepressants: quality-control considerations. Orsulak PJ; Gerson B Ther Drug Monit; 1980; 2(3):233-42. PubMed ID: 7222178 [TBL] [Abstract][Full Text] [Related]
18. Mirtazapine: not a dual action antidepressant? Gillman PK Aust N Z J Psychiatry; 2004 Apr; 38(4):266-7. PubMed ID: 15038808 [No Abstract] [Full Text] [Related]
19. Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs. Koszewska I; Rybakowski JK Neuropsychobiology; 2009; 59(1):12-6. PubMed ID: 19221443 [TBL] [Abstract][Full Text] [Related]